krn-7000
Small moleculeexperimental
Clinical trial activity
5 trials · 10 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 1998 (NCT00003985)
Timeline
Indications
Mechanism of action
- Antigen-presenting glycoprotein CD1dACTIVATOR
CD1D activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- krn7000
- krn7000
- krn7000
- krn 7000
- krn-7000
- krn-7000
- krn 7000, 1s-(1r*,2r*,3s*)-beta-d-galacto isomer
- rgi-2001
- rgi-2001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07246031 | Phase 2 | Oct 29, 2025 | BioPhoenix Co., Ltd., Peking University |
| NCT01379209 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2011 | Pacific-Link Consulting, Regimmune Inc. |
| NCT00352235 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2003 | Foundation for Liver Research, Free University of Amsterdam, Kyowa Hakko Kirin |
| NCT00363155 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2003 | Erasmus University Rotterdam, Foundation for Liver Research |
| NCT00003985 | Phase 1 | Sep 1, 1998 | European Organisation for Research and Treatment of Cancer, Leiden University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (10)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Foundation for Liver Research | Academic/Hospital | 2 | 2 | 1 | 2003 |
| BioPhoenix Co., Ltd. | For profit | 1 | 1 | 1 | 2025 |
| Erasmus University Rotterdam | Academic/Hospital | 1 | 0 | 1 | 2003 |
| European Organisation for Research and Treatment of Cancer | Academic/Hospital | 1 | 1 | 1 | 1998 |
| Free University of Amsterdam | Academic/Hospital | 1 | 0 | 1 | 2003 |
| Kyowa Hakko Kirin | For profit | 1 | 0 | 1 | 2003 |
| Leiden University | Academic/Hospital | 1 | 0 | 1 | 1998 |
| Pacific-Link Consulting | For profit | 1 | 0 | 1 | 2011 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Regimmune Inc. | For profit | 1 | 1 | 1 | 2011 |
10 organizations
Page 1 / 1